chloroquine has been researched along with Mucopolysaccharidosis II in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Mucopolysaccharidosis II: Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeda, M | 1 |
| Seto, T | 1 |
| Kadono, C | 1 |
| Morimoto, H | 1 |
| Kida, S | 1 |
| Suga, M | 1 |
| Nakamura, M | 1 |
| Kataoka, Y | 1 |
| Hamazaki, T | 1 |
| Shintaku, H | 1 |
1 other study available for chloroquine and Mucopolysaccharidosis II
| Article | Year |
|---|---|
Autophagy in the Central Nervous System and Effects of Chloroquine in Mucopolysaccharidosis Type II Mice.
Topics: Animals; Autophagy; Brain; Chloroquine; Iduronate Sulfatase; Male; Mice; Mice, Inbred C57BL; Microgl | 2019 |